Compuls-BED-Severity

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-03-07

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* Binge Eating Disorder (BED) has been fairly recently introduced into the Diagnostic and Statistical Manual 5 psychiatric classification and its severity criteria are still not well established.
* Moreover, it remains unclear whether BED is associated with greater metabolic severity or more somatic comorbidities, especially in obesity.
* Improved BED severity staging could lead to a better definition of management strategies and , therefore, facilitate screening and care.

The investigators' hypothesis is that an improved assessment of the impulsivity-compulsivity spectrum, emotional regulation, attentional impairment and somatic or psychiatric comorbidities will result in a better distinction between the severe form of BED (e.g., highly impulsive and somatically complicated) from milder form (e.g., more compulsive and less somatically complicated).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)

NCT05879679

Bulimia Nervosa Binge-Eating Disorder

RECRUITING

Binge Eating Disorder and Obesity : Functional MRI Study

NCT02868619

Binge Eating Disorder Obesity

COMPLETED NA

Quality of Life in Binge Eating Disorder.

NCT05010798

Binge-Eating Disorder Quality of Life

COMPLETED

Improving Weight Loss Outcomes for Binge Eating Disorder.

NCT03712462

Eating Disorder Binge-Eating Disorder Weight Loss +1 more

COMPLETED NA

Treatment for Obesity and Binge Eating Disorder

NCT00537758

Binge Eating Disorder Obesity

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Binge-Eating Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BED+ : Participants with obesity and binge eating disorder

Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 positive score and a Binge Eating Scale score \>16

Observational

Intervention Type OTHER

(no intervention)

BED-: Participants with obesity but without binge eating disorder

Obesity is define by a BMI ≥ 30 kg.m-2 Binge eating disorder is defined by Binge Eating Disorder Screener (BEDS)-7 negative score and a Binge Eating Scale score \< 12

Observational

Intervention Type OTHER

(no intervention)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Observational

(no intervention)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* men or women aged 1
* participants eligible for bariatric surgery (BMI\>40, or BMI\>35 with severe comorbidities)
* participants scheduled for medical evaluation and treatment of obesity at the IUCPQ Obesity Clinic (BMI≥30)
* participants scheduled for evaluation and treatment of BED at the CEPIA with obesity (BMI≥30)
* for the group with BED: positive BEDS-7 screen and Binge Eating Scale score \>16;
* for the control group: have a negative BEDS-7 screen and Binge Eating Scale score\<12
* be fluent in French and able to consent.

Exclusion Criteria

* participants with severe neurological disorder and/or major neurocognitive deficits;
* participants with previous bariatric surgery or with introduction or change of anti-obesity medication (liraglutide or naltrexone/bupropion) in the previous 3 months;
* participants who cannot read and/or understand French;
* participants under guardianship or curatorship;
* participants already included in a study with a conflict of interest with this study;
* inability to use a computer or iPad;
* inability to access an Internet connection or to visit one of the inclusion sites.

* participants with a discordance between BEDS-7 (positive) and Binge Eating Scale (score ≤ 16) results found secondarily
* participants who did not participate in part of the assessments (e.g., self-questionnaires or neurocognitive tests) and participants with a rate of missing data\>10%.

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No